Clinical Trial Update: Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating immunotherapy to induce peanut tolerance, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy
• Peanut Allergy

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Food Hypersensitivity | Phase 2 | Status: COMPLETED | Results posted: 2018-05-24